CMMB
Chemomab Therapeutics
CMMB
CMMB
17 hedge funds and large institutions have $1.47M invested in Chemomab Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$72.3K |
| 2 |
2
Two Sigma Investments
New York
|
$28.7K |
| 3 |
3
Two Sigma Advisers
New York
|
$18.1K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$16.7K |
| 5 |
XT
5
XTX Topco
George Town,
Cayman Islands
|
$14.8K |
